PTU - Polskie Towarzystwo Urologiczne
list of articles:

THE COMPARISON OF LOCAL STAGE PERFORMED BY DIGITAL RECTAL EXAMINATION (TDRE) AND TRANSRECTAL ULTRASONOGRAPHY (TTRUS) TO HISTOPATHOLOGICAL STAGE (pT)
Article published in Urologia Polska 2000/53/2.

authors

Romuald Zdrojowy
Katedra i Klinika Urologii Akademii Medycznej we Wroc³awiu
Kierownik Kliniki: prof. dr hab. med. J. Lorenz

keywords

prostate adenocarcinoma local stage DRE, TRUS

summary

Objectives. One of the most important factor to introduce the suitable mode
of treatment in patients with prostate cancer is the proper and accurate local
stage diagnosis. Its reliability and accuracy is only possible by Comparing to
histopathological stage. The aim of the study was the appreciation of clinical
local stage performed by digital rectal examination (TDRE) and transrectal
ultrasonography (TTRUS) to stage made by histopathological examination of
radical prostatectomy specimen.
Material and methods. The clinical local stage of prostate cancer was
performed by DRE (TDRE) and TRUS (T ). On the base of DRE the tumour
presence, its size and relationship to adjacent tissues were evaluated, so the
local stage TDRE was determined. In transrectal ultrasonography the tumour
size, its relations to prostate capsule and seminal vesicles as well as adjacent
tissues and organs were evaluated - so the local stage TTRUS was established.
Finally the clinical local stage (T) was defined as the most advanced local stage
either in DRE or in TRUS. The clinical stage (T) were compared to pathological
stage (pT) in 98 men treated later by radical retropubic prostatectomy.
Results. It was statistically proved, that histopathological stage (pT) was
significantly different from clinical stage (T) ? = 0.05). The histopathological stage
pT
and in 2% clinical understaging was observed. The clinical stage performed by
ultrasound examination (TTRUS) was the most reliable result compared to
pathological stage (pT); 87% of TTRUS were consistent to pT (p = 0.0075).
Up to 80% TDRE were understaged but never TDRE overstaging was observed.
The DRE sensivity according to cancer extracapsular extension was only 22%
but specificity was then 100%.
Conclusions. The clinical stage in men with prostate cancer may differs from
pathological stage performed after radical prostatectomy specimen examination.
The stage established by ultrasound examination is the most reliable result
according to histopathological examination. The local stage performed by DRE
is more often understaged.

references

  1. [1] Bostwick, D. G.: Staging prostate cancer - 1997: current methods and limita-
  2. tions. Eur. Urol. 1997, 32, Suppl. 3, 2-14.
  3. [2] Carroll, P. R.: Prostate cancer 1996: efficient use of imaging and new treatment
  4. techniques. Prostate cancer treatment: stage by stage. 9655 postgraduate course.
  5. 91st AUA Annual Meeting, Office of Education, Orlando 1996,1-10.
  6. [3] Chodak, G. W., Schoeneberg, H. W.: Early detection of prostate cancer by
  7. routine screening. JAMA, 1984, 252, 3261-3268.
  8. [4] Dimopoulos, C: Difficulties in assessing local spread of prostate cancer. Eur.
  9. Urol. Today 1997, 7, 8-9.
  10. [5] Gibbons, R. P.: Prostate Carcinoma. Surgical management of regional disease.
  11. Cancer 1996, 78, 2455-2460.
  12. [6] Hamdy, F. C, Fortling, B., Humphries, K.: Staging of prostate cancer using
  13. three-dimensional transrectal ultrasound imaging: a pilot study. J. Urol. 1997,157,
  14. (Suppl. 4), 325.
  15. [7] Hrouda, D., Kirby, R. S.: Radical prostatectomy in advanced prostate carcino-
  16. ma: the case against. Eur. Urol. Update Series 1998, 7,157-162.
  17. [8] International Union Against Cancer: Sobin, L. H., Wittekind, C: TNM
  18. classification of malignant tumours. Wiley-Liss, New York 1997,170.
  19. [9] Lee, F., Littrup, P. J., Torp-Pedersen, S. T., Mettlin, C, McHugh, T. A.,
  20. Gray, J. M., Kumasaka, G. H., McLeary, R. D.: Prostate cancer: comparison
  21. of transrectal US and digital rectal examination for screening. Radiology 1988,
  22. 168, 389-394.
  23. [10] McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S., Stamey, T.
  24. A.: Capsular penetration in prostate cancer: significance for natural history and
  25. treatment. Amer. J. Surg. Path. 1990,14, 240-247.
  26. [11] Mukamel, E., de Kernion, J. E., Hannah, J.: The incidence and significance
  27. of seminal vesicle invasion in patients with adenocarclnoma of the prostate. Cancer
  28. 1987, 59,1535-1538.
  29. [12] Narayan, P., Gajendran, V., Taylor, S. P.: The role of transrectal ultrasound-
  30. guided biopsy-based staging, preoperative serum prostate-specific antigen and biopsy
  31. Gleason score in prediction to final pathologic diagnosis in prostate cancer. Urolo-
  32. gy 1995, 46, 205-212.
  33. [13] Perrotti, M., Fair, W. R.: Okreslanie stopnia zaawansowania u chorych z nowo
  34. rozpoznanym rakiem stercza. AUA Update Series 1999, 16, 198-206.
  35. [14] Ravery, V., Boccon-Gibod, L.: The staging of clinically localized prostatic can-
  36. cer. Eur. Urol. Update Series, 1995, 4, 90-95.
  37. [15] Rifkin, M. D., Zerhouni, E. A., Gatsonis, C. A., Quint, L. E., Paushter,
  38. D. M., Epstein, J. I., Hamper, U., Walsh, P. C, McNeil, B. J.: Comparison
  39. of magnetic resonance imaging and ultrasonography in staging early prostate can-
  40. cer: results of a multi-institutional cooperative trial. N. Engl. J. Med. 1990, 323,
  41. 621-626.
  42. [16] Rosen, M. A., Goldstone, L., Lapin, S., Wheeler, T., Scardino, P. T.:
  43. Frequency and location of extracapsular extension and positive surgical margins in
  44. radical prostatectomy specimens. J. Urol. 1992, 148, 331-337.
  45. [17] Schroder, F. H., Hermanek, P., Denis, L., Fair, W. R., Gospodarowicz,
  46. M. K., Pavone-Macaluso, M.: The TNM classification of the prostate carcino-
  47. ma. Prostate 1992, 4, suppl., 129-136.
  48. [18] Schroder, F. H., van den Ouden, D., Davidson, P.: The limits of surgery in
  49. the cure ofprostatic carcinoma. Eur. Urol. Update Series 1992,1,18-23.
  50. [19] Simak, R., Eisenmenger, M., Hainz, A., Kratzik, C, Marberger, M.: Is
  51. transrectal ultrasonography needed to rule out prostatic cancer with normal fin-
  52. dings at digital rectal examination and normal serum prostate-specific antigen?
  53. Eur. Urol. 1993, 24, 474-478.
  54. [20] Zincke, H., Utz, D. C, Taylor, W. F.: Bilateral pelvic lymphadenectomy and
  55. radical prostatectomy for clinical stage C prostate cancer: role of adjuvant treat-
  56. ment for residual cancer and in disease progression. J. Urol. 1986,135,1199-1206.